Rimon

Entries tagged “securities law”

Rimon represents Tinybeans Group Ltd. on quotation of its shares on OTCQX

news Rimon represents Tinybeans Group Ltd. on quotation of its shares on OTCQX Andrew Reilly · September 25, 2020

On September 23, 2020, Rimon client Tinybeans Group Ltd, a Sydney and New York-based social media platform, listed on the OTCQX®  under the symbol TNYYF.  The company upgraded to OTCQX from the Pink® market. Tinybeans was advised by Rimon Partner Andrew Reilly, who is well known for his work helping Australian and New Zealand companies to list on foreign exchanges, most notably in…

Continue Reading…

International Corporate and Securities Law Attorney, James Chapman, joins Rimon as Partner in its Palo Alto Office

news International Corporate and Securities Law Attorney, James Chapman, joins Rimon as Partner in its Palo Alto Office James C. Chapman · May 9, 2017

James Chapman joins Rimon, P.C. as partner in its Palo Alto office. Mr. Chapman focuses his practice on securities law, venture capital, mergers and acquisitions, and international business transactions. He counsels publicly traded and privately held clients on public offerings, private placements, debt financings, venture capital transactions, mergers and acquisitions, and related transactions. Mr. Chapman…

Continue Reading…

SEC Loosens Control on Shareholder Limit under the Private Company Flexibility and Growth Act

insights SEC Loosens Control on Shareholder Limit under the Private Company Flexibility and Growth Act Michael Moradzadeh · November 1, 2011

This blog post was prepared by Inna S. Wood and Michael Moradzadeh. The Private Company Flexibility and Growth Act (H.R. 2167), referred to as the “Facebook Rule” by many internet bloggers, was introduced in the House by Rep. David Schweikert (R-AZ) on June 14, 2011. Its main theme is to increase the shareholders of record…

Continue Reading…

Supreme Court Rejects “Statistical Significance” as Threshold for Required Securities Disclosure

insights April 6, 2011

In Matrixx Initiatives et al. v. Siracusano et al, the unanimous Court held that a pharmaceutical company may be liable for securities fraud by failing to disclose a statistically insignificant number of adverse reactions to a cold medication.   The Supreme Court issued a decision on March 22, 2011 that may help securities class action plaintiffs…

Continue Reading…

SEC Proposes Amendments to Accredited Investor Status

insights February 16, 2011

The SEC recently voted to propose amendments to the net worth standard for determining accredited investor status under the Securities Act of 1933.  Under the proposal, the SEC’s rules would be amended to exclude the value of an individual’s primary residence in calculating net worth for the purposes of determining whether a person qualifies as…

Continue Reading…